Personalis Inc (PSNL)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $1.70B
Last updated: Nov 17, 2026 at 11:06 AM ET
Personalis Inc (PSNL) Stock Forecast
Analysts expect Personalis (PSNL) to earn -$1.16 per share in the fiscal year ending Dec 31, 2026, on revenue of $88.65M. Of 5 analysts, 1 rates the stock Buy or Strong Buy, 4 Hold and 0 Sell or Strong Sell, for a consensus of Hold. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$0.98.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 5 ratings average 2.80, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 20% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 1 | 20.0% |
| Hold | 4 | 80.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Hold
- Total analysts
- 5
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 24.6%.
- Fiscal year ending Dec 31, 2026
- -$1.16
- EPS consensus, revenue $88.65M
- Fiscal year ending Dec 31, 2027
- -$0.98
- EPS consensus, revenue $110.46M
- Next report
- Feb 24, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$1.16 | -$1.21 to -$1.10 | 2 | $88.65M | $87.10M to $90.20M | 2 |
| Dec 31, 2027 | -$0.98 | -$1.18 to -$0.84 | 5 | $110.46M | $103.60M to $118.10M | 5 |
Quarterly Estimates
The EPS consensus rises from -$0.25 for the quarter ending Dec 31, 2026 to -$0.23 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.25 | -$0.31 to -$0.21 | 9 | $25.53M | $22.64M to $28.04M | 8 |
| Mar 31, 2027 | -$0.23 | -$0.25 to -$0.22 | 3 | $23.24M | $19.60M to $28.80M | 3 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 1 upward and 0 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 0 |
| Fiscal year ending Dec 31, 2027 | 1 | 0 |
| Quarter ending Mar 31, 2027 | 0 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$1.09.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$1.16 | -$1.21 | -$1.08 | -$1.09 | -$1.09 | N/A |
| Fiscal year ending Dec 31, 2027 | -$0.98 | -$0.97 | -$0.94 | -$0.94 | -$0.94 | N/A |
| Quarter ending Mar 31, 2027 | -$0.23 | -$0.23 | -$0.23 | -$0.23 | -$0.23 | N/A |
Frequently Asked Questions About PSNL
What is the PSNL stock forecast?
Consensus analyst estimates put Personalis's EPS at -$1.16 for the fiscal year ending Dec 31, 2026, on revenue of $88.65M. The consensus rating from 5 analysts is Hold.
How do analysts rate PSNL stock?
Of 5 analysts covering Personalis, 0 rate it Strong Buy, 1 Buy, 4 Hold, 0 Sell and 0 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from PSNL next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$1.16, with estimates from -$1.21 to -$1.10 from 2 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.98, with estimates from -$1.18 to -$0.84 from 5 analysts.
What revenue do analysts expect from Personalis next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $88.65M, with estimates from $87.10M to $90.20M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $110.46M, with estimates from $103.60M to $118.10M.
How many analysts cover PSNL?
5 analysts rate Personalis stock, and 2 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
PSNL pages: Overview, Earnings, Forecast, Financials, Competitors, Government Contracts